Canada
· Delayed Price · Currency is CAD Hydreight Technologies Statistics
Total Valuation
TSXV:NURS has a market cap or net worth of CAD 47.59 million. The enterprise value is 46.38 million.
| Market Cap | 47.59M |
| Enterprise Value | 46.38M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:NURS has 42.88 million shares outstanding. The number of shares has increased by 20.76% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 42.88M |
| Shares Change (YoY) | +20.76% |
| Shares Change (QoQ) | +3.40% |
| Owned by Insiders (%) | 4.00% |
| Owned by Institutions (%) | n/a |
| Float | 15.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.79 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -35.63 |
| EV / Sales | 3.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 112.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 5.98 |
| Inventory Turnover | 133.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +286.44% in the last 52 weeks. The beta is 0.44, so TSXV:NURS's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +286.44% |
| 50-Day Moving Average | 1.60 |
| 200-Day Moving Average | 0.89 |
| Relative Strength Index (RSI) | 38.96 |
| Average Volume (20 Days) | 46,462 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:NURS had revenue of CAD 15.38 million and -1.30 million in losses. Loss per share was -0.03.
| Revenue | 15.38M |
| Gross Profit | 5.89M |
| Operating Income | -1.09M |
| Pretax Income | -1.30M |
| Net Income | -1.30M |
| EBITDA | -918,123 |
| EBIT | -1.09M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 1.21 million in cash and n/a in debt, giving a net cash position of 1.21 million or 0.03 per share.
| Cash & Cash Equivalents | 1.21M |
| Total Debt | n/a |
| Net Cash | 1.21M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | -1.78M |
| Book Value Per Share | -0.04 |
| Working Capital | -2.22M |
Cash Flow
| Operating Cash Flow | 375,758 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.33%, with operating and profit margins of -7.07% and -8.47%.
| Gross Margin | 38.33% |
| Operating Margin | -7.07% |
| Pretax Margin | -8.47% |
| Profit Margin | -8.47% |
| EBITDA Margin | -5.97% |
| EBIT Margin | -7.07% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:NURS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.76% |
| Shareholder Yield | -20.76% |
| Earnings Yield | -2.74% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.
| Last Split Date | Nov 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1546061 |
Scores
TSXV:NURS has an Altman Z-Score of 0.18. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.18 |
| Piotroski F-Score | n/a |